Medicover AB (LTS:0RPS) Cyclically Adjusted PS Ratio: (As of Jul. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0RPS Medicover AB LTS:0RPS
90 GF Score
Price kr220.00
GF Value kr234.60
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Medicover AB Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Medicover AB  (LTS:0RPS) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Medicover AB Cyclically Adjusted PS Ratio Related Terms


Medicover AB Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Medicover AB's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicover AB Cyclically Adjusted PS Ratio Chart

Medicover AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 2.07

Medicover AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.45 2.48 2.07 1.71 0.00

LTS:0RPS vs HCA, THC, DVA: Cyclically Adjusted PS Ratio Comparison

For the Medical Care Facilities subindustry, Medicover AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicover AB Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medicover AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medicover AB's Cyclically Adjusted PS Ratio falls into.


LTS:0RPS
90GF Score
Medicover AB LTS:0RPS
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicover AB Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Medicover AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Medicover AB's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=46.195/134.1100*134.1100
=46.195

Current CPI (Jun. 2026) = 134.1100.

Medicover AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 12.292 101.138 16.299
201612 13.426 102.022 17.649
201703 10.147 102.022 13.339
201706 12.273 102.752 16.018
201709 10.310 103.279 13.388
201712 11.285 103.793 14.581
201803 12.338 103.962 15.916
201806 12.423 104.875 15.886
201809 13.096 105.679 16.619
201812 13.961 105.912 17.678
201903 15.727 105.886 19.919
201906 16.178 106.742 20.326
201909 17.009 107.214 21.276
201912 18.055 107.766 22.469
202003 19.480 106.563 24.516
202006 15.235 107.498 19.007
202009 18.456 107.635 22.996
202012 20.410 108.296 25.275
202103 21.746 108.360 26.914
202106 23.792 108.928 29.292
202109 22.964 110.338 27.911
202112 26.052 112.486 31.060
202203 27.104 114.825 31.656
202206 25.794 118.384 29.221
202209 26.731 122.296 29.313
202212 29.352 126.365 31.151
202303 31.427 127.042 33.176
202306 33.111 129.407 34.314
202309 34.822 130.224 35.861
202312 34.526 131.912 35.101
202403 37.538 132.205 38.079
202406 38.300 132.716 38.702
202409 39.910 132.304 40.455
202412 42.582 132.987 42.942
202503 41.944 132.825 42.350
202506 43.525 133.699 43.659
202509 43.106 133.480 43.309
202512 44.090 133.390 44.328
202603 44.241 133.560 44.423
202606 46.195 134.110 46.195

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Medicover AB (LTS:0RPS) Overvalued in 2026?

Based on GuruFocus' analysis, Medicover AB stock appears to be undervalued. The current stock price of kr220.00 is trading 6.2% below its estimated GF Value™ of kr234.60. GuruFocus considers Medicover AB to be Fairly Valued.

Key valuation signals for LTS:0RPS:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: kr234.60 vs. price of kr220.00 (6.2% below fair value)
  • GF Score™: 90/100 with 5 warning signs

No single metric tells the full story. See the LTS:0RPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medicover AB Business Description

Address Riddargatan 12A, P.O. Box 5283, Stockholm, SWE, 102 46
Medicover AB is an international healthcare and diagnostic services provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. Medicover offers its services through two reportable segments: Healthcare Services, which generates the maximum revenue, and Diagnostic Services. Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas, and Healthcare Services offer medical care and related services by operating on an Integrated Healthcare and Fee-For-Service model across different countries. Geographically, the company derives maximum revenue from Germany, and the rest from Poland, India, Ukraine, Romania, and other countries.
90GF Score

Get the complete analysis for LTS:0RPS

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr220.00
Price
kr234.60
GF Value